Doris Steinemann

Prof. Dr. rer. nat.

Medizinische Hochschule Hannover

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Medical Science Medical Science professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof. Dr. rer. nat. Doris Steinemann is a professor at Medizinische Hochschule Hannover in Germany. Her research areas include genetic alterations in hematological malignancies, particularly childhood acute lymphoblastic leukemia (ALL) and myelodysplastic syndromes. She has contributed to significant findings in gene editing techniques and the clinical characteristics of pediatric leukemia associated with genetic syndromes.

Articles (9)

Year:

2025

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Jared Sterneckert

Professor Dr. at Technische Universität Dresden

Technische Universität Dresden

GERMANY

View details

Lisa Russell

Senior Lecturer in Childhood Cancer and Haematology

Newcastle University

UNITED KINGDOM

View details

Konstantin Riege

Leibniz Institute on Aging – Fritz Lipmann Institute

GERMANY

View details

Hélène Cavé

PUPH, Head of the molecular Genetics unit

Hôpital Robert-Debré

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Doris Steinemann

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome

Genetic alterations in lymphoblastic leukaemia / lymphoma – a practical guide to WHO HAEM5

Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL

A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines.

BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone

Unbalanced translocation der(5;17) resulting in a TP53 loss as recurrent aberration in myelodysplastic syndrome and acute myeloid leukemia with complex karyotype

Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li–Fraumeni syndrome

From a variant of unknown significance to pathogenic: Reclassification of a large novel duplication in BRCA2 by high‐throughput sequencing

Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells

Collaborators (4)

Jared Sterneckert

Lisa Russell

Konstantin Riege

Hélène Cavé

Make your next move.